Clin2
NCT06416397Likely a fitRecruiting

Bile test for bile duct cancer diagnosis

Cholangiocarcinoma

Part of Cancer clinical trials.

This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Age 18 or older
  • Have a narrowing (stenosis) in the bile duct
  • Need a procedure called endoscopic retrograde cholangiography or a radiology procedure to take tissue samples
  • Not be pregnant
  • Not be under legal guardianship

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06780553Not yet recruiting
Testing a protein test to diagnose bile duct cancer

This study is testing if a new protein-based lab test can better identify bile duct cancer from stored tissue samples. It's looking for people who had a bile duct sample taken but don't yet have a clear cancer diagnosis.

Pessac
NCT07007832Recruiting
Bile test to diagnose unclear bile duct narrowings

This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.

Shanghai, China
NCT06658587Not yet recruiting
Blood test for early detection of bile duct cancer

This study is testing a new way to use a simple blood test to help diagnose cholangiocarcinoma (bile duct cancer) earlier and more accurately. It is for people whose tumors can be surgically removed and who have not had prior cancer treatment.

Guangzhou, Guangdong
NCT06474091Enrolling by invitation
Blood monitoring for bile duct cancer treatment and outlook

This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.

Rochester, Minnesota
NCT07206355Recruiting
Studying bile duct and liver lesions for new cancer tests

This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.

Nottingham
NCT05184400Recruiting
Find new blood or tumor markers for bile duct and gallbladder cancer

This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.

Herlev, Copenhagen

Hear when a new Cholangiocarcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.